2023 NEWS RELEASES
Global Wellness Readies for First Clinical Trial
Vancouver, British Columbia, May 12, 2022 – Global Wellness Strategies Inc. (CSE:GWS) (OTCQB:GWSFF) (Frankfurt:O3X4) (“Global” or the “Company”) announces Shanti Therapeutics MDMA Clinical Trial Update.
World-Renowned Dr. Sud Agarwal Joins Global Wellness Strategies
Vancouver, British Columbia, May 9, 2022 – Global Wellness Strategies Inc. (CSE:GWS) (OTCQB:GWSFF) (Frankfurt:O3X4) (“Global” or the “Company”) welcomes world-renowned Dr. Sud Agarwal as the chief
Global Wellness’ KaleidoMyco Brand Introduces FIRST EVER Effervescent Tablets Combining Functional Mushrooms + Hemp Extract
Vancouver, British Columbia, April 12, 2022 – Global Wellness Strategies Inc. (CSE: GWS) (Frankfurt:O3X4) (OTCQB: GWSFF) (“Global” or the “Company”) today announces their brand KaleidoMyco will
2022 NEWS RELEASES
2021 NEWS RELEASES
Global Wellness Introduces KaleidoMyco’s Trifecta Powder-In-Capsule
Vancouver, British Columbia, March 31, 2021– Global Wellness Strategies Inc. (formerly Redfund Capital Corp.)(CSE: LOAN) (Frankfurt:O3X4) (OTC QB: PNNRF) (“Global” or the “Company”) introduces KaleidoMyco’s
Global Wellness Strategies Unveils First New Product for KaleidoUSA
Vancouver, British Columbia, March 4, 2021 – Global Wellness Strategies Inc. (formerly Redfund Capital Corp.)(CSE: LOAN) (Frankfurt:O3X4) (OTC QB: PNNRF) (“Global” or the “Company”) unveils
Global Wellness Strategies Announces Acquisition of KaleidoUSA Myco-Dosing Innovator
Vancouver, British Columbia, February 26, 2021– Global Wellness Strategies Inc. (formerly Redfund Capital Corp.)(CSE: LOAN) (Frankfurt:O3X4) (OTC QB: PNNRF) (“Global” or the “Company”) announces it
